Group 1 - The core point of the article is that Beijing Qilun Tianyou Venture Capital Co., Ltd., a shareholder holding 6.18% of Aojing Medical (688613), plans to reduce its stake by up to 1% through centralized bidding and block trading, amounting to no more than 1.3555 million shares [1]

Group 1 - The core point of the article is that Beijing Qilun Tianyou Venture Capital Co., Ltd. plans to reduce its stake in Aojing Medical Technology Co., Ltd. by up to approximately 1% of the total shares, which amounts to about 136 million shares [1] - As of the announcement date, Qilun Tianyou holds approximately 8.47 million shares, representing 6.18% of Aojing Medical's total shares [1] - The shares to be reduced were acquired before the company's initial public offering and have been tradable since May 23, 2022 [1] Group 2 - The reduction will be executed through centralized bidding and block trading, with specific timelines for each method [1] - The centralized bidding reduction will take place within three months after the 15 trading days following the announcement, while the block trading will follow the same timeline [1]

Group 1 - The core point of the article is that BioVeda China RMB Investment Limited has reduced its stake in Aojing Medical by selling 388,900 shares, bringing its total holdings to 6.8504 million shares, which now represents 5% of the company's total equity, down from 5.28% [1] - The reduction in shareholding was a voluntary decision made by the shareholder based on its own funding needs, and there is a possibility of further reductions within the next 12 months [1] - The shares held by the shareholder are not subject to any pledges or restrictions such as freezing [1]

奥精医疗公告，股东北京奇伦天佑创业投资有限公司持有公司846.8万股，占6.18%，计划通过集中竞 价、大宗交易方式减持不超过135.55万股，即不超过1%，减持期为2025年10月23日至2026年1月23日， 减持原因为自身资金安排。 ...

Summary of Key Points Core Viewpoint - Aojing Medical (688613) has seen a notable increase in stock price, closing at 27.13 yuan as of September 19, 2025, which is a 4.75% rise from the previous week [1]. Trading Information - On September 16, Aojing Medical recorded a significant block trade with institutional net purchases amounting to 9.83 million yuan. - On September 15, another block trade occurred with institutional net purchases of 9.21 million yuan. - Over the two days, the total institutional net purchases reached 19.04 million yuan [1][3]. Company Announcements - Aojing Medical held its second extraordinary general meeting of shareholders on September 15, 2025, where a legal opinion was provided by Beijing Zhonglun Law Firm. - The meeting approved the proposal to supplement the non-independent director of the second board of directors. - A total of 48 shareholders and authorized agents attended the meeting, representing 21,634,885 shares, which is 15.79% of the total share capital on the record date [1].

近5日融资融券数据一览见下表： 证券之星消息，截至2025年9月17日收盘，奥精医疗(688613)报收于27.8元，下跌2.52%，换手率 7.11%，成交量9.74万手，成交额2.71亿元。 9月17日的资金流向数据方面，主力资金净流入2625.12万元，占总成交额9.68%，游资资金净流出 954.34万元，占总成交额3.52%，散户资金净流出1670.78万元，占总成交额6.16%。 近5日资金流向一览见下表： | | | | | 日期 收盘价 涨跌幅 主力净流入 主力净占比 游资净占比 散户净流入 散户净占比 | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 2025-09-17 | 27.80 -2.52% | | 2625.12万 | 9.68% | -954.34万 | -3.52% | -1670.78万 | -6.16% | | 2025-09-16 | 28.52 | 6.78% | -1487.58万 | -3.13% | 1582.69万 | 3.33% | -95.11万 | -0.20% | | ...

第1笔成交价格为28.09元，成交35.00万股，成交金额983.15万元，溢价率为-1.51%，买方营业部为机构 专用，卖方营业部为华泰证券股份有限公司南京中山东路华泰证券大厦证券营业部。 进一步统计，近3个月内该股累计发生7笔大宗交易，合计成交金额为5525.6万元。该股近5个交易日累 计上涨7.26%，主力资金合计净流出2092.94万元。 责任编辑：小浪快报 炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！ 9月16日，奥精医疗收涨6.78%，收盘价为28.52元，发生1笔大宗交易，合计成交量35万股，成交金额 983.15万元。 ...

Group 1 - On September 16, Aojing Medical executed a block trade of 350,000 shares, with a transaction value of 9.8315 million yuan, accounting for 2.03% of the total transaction volume for that day [1] - The transaction price was 28.09 yuan, which represents a discount of 1.51% compared to the market closing price of 28.52 yuan [1]

Summary of Key Points Core Viewpoint - On September 15, 2025, Aojing Medical (688613) closed at 26.71 yuan, marking a 3.13% increase with a turnover rate of 9.04% and a trading volume of 123,800 shares, resulting in a transaction value of 336 million yuan [1]. Trading Information - On September 15, the net inflow of main funds was 16.1 million yuan, accounting for 4.79% of the total transaction value [1][3]. - Retail investors experienced a net outflow of 4.2 million yuan, representing 1.25% of the total transaction value [1]. - A significant block trade occurred on September 15, with institutional net purchases amounting to 9.2 million yuan [1][3]. Company Announcements - Aojing Medical held its second extraordinary general meeting of shareholders in 2025 on September 15, where the proposal to supplement the non-independent directors of the second board was approved [1][3]. - The meeting was convened by the company's board and took place at the Beijing Daxing Biomedical Industry Base, with a combination of on-site and online voting [1]. - A total of 48 shareholders and authorized agents attended the meeting, representing 21,634,885 shares with voting rights, which is 15.79% of the total share capital on the registration date [1].

本次会议是否有被否决议案：无 一、 会议召开和出席情况 （一） 股东大会召开的时间：2025 年 9 月 15 日 证券代码：688613 证券简称：奥精医疗 公告编号：2025-051 奥精医疗科技股份有限公司 2025年第二次临时股东大会决议公告 本公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： （二） 股东大会召开的地点：北京市大兴区庆丰西路 69 号 35 号楼 3 层 （三） 出席会议的普通股股东、特别表决权股东、恢复表决权的优先股股东及 其持有表决权数量的情况： | 1、出席会议的股东和代理人人数 | 48 | | --- | --- | | 普通股股东人数 | 48 | | 2、出席会议的股东所持有的表决权数量 | 21,634,885 | | 普通股股东所持有表决权数量 | 21,634,885 | | 3、出席会议的股东所持有表决权数量占公司表决权数量的比 | 15.7908 | | 例（%） | | | 普通股股东所持有表决权数量占公司表决权数量的比例（%） | 15.7908 | （四） ...